American Gene Technologies, a clinical-stage biotechnology company, has appointed Jeff Boyle, PhD as chief science officer. Dr. Boyle comes to the post with deep biotechnology expertise which will help further accelerate the company’s FDA-approved HIV gene therapy clinical trial that expects to see first indications of efficacy in Q3, as well as continue the developments in monogenic disease and immuno-oncology.
Michael Doub has enjoyed a diverse professional path working in both the life sciences and manufacturing. Before coming to Eastern Analytical Labs, Michael co-founded Aireon Therapeutics Inc. where he served as CEO. Michael has a successful record of building operational systems and high performing teams that drive organizational growth from concept to commercialization. He has received a BA in Biology from Hood College, an MBA from University of Maryland and Operational Efficiency Certifications from Villanova University.
Tanner Ash recently joined BioNTech as Senior Specialist, Quality Assurance Operations. Tanner was most recently a Supervisor at Ellume, a global diagnostics company that develops, manufactures, and commercializes the next generation of digitally enabled diagnostic products for healthcare professionals and consumers.
In addition to his work with Ellume, over the past decade Tanner has held positions with Kite, VaLogic, and Lonza.
Brian Stamper recently joined Immunomic Therapeutics, Inc. as Vice President, Cell Therapy Operations. Brian has over 20 years of experience in the biopharmaceutical industry, including increasingly responsible management positions in various operational areas including cell therapy operations, biotechnology manufacturing, and process engineering.
Scott is detail-oriented, conscientious, and highly skilled at his craft, with 16+ years of experience working in a GMP environment, delivering high-impact results through an effective combination of fine-tuned technology/technical expertise, acute attention to detail, troubleshooting skills, seamless project management, and interpersonal communication techniques. He is a technology enthusiast who strives for perfection and is effective at multitasking in a highly dynamic, challenging, and fast-changing environment while juggling multiple priorities simultaneously and remaining focused.
Former lab scientist Alexis Staten recently joined Workforce Genetics (WFGX) as a Life Sciences Recruiter. Alexis brings a unique background in customer service and lab experience to her new role. She joins an experienced, growing biopharma talent recruiting team at Workforce Genetics and joins Paul Streng, another recent hire, as a former scientist turned life sciences recruiter.
NRx Pharmaceuticals, Inc. (Nasdaq: NRXP), a clinical-stage biopharmaceutical company, announced today that the company’s Board of Directors appointed Seth Van Voorhees, Ph.D. as Chief Financial Officer and Treasurer effective June 13, 2022.
Former scientist and veteran life sciences recruiter Paul Streng recently joined Workforce Genetics (WFGX) as a Senior Life Science Talent Consultant. Paul brings a wealth of diverse experience to his new role, including a successful executive recruiting track record coupled with deep experience as a lab supervisor, a field application scientist and a life science product manager and marketer.
At MSCRF, Ben is responsible for management and oversight of the research portfolio. In this role, Ben aspires to develop and support stem cell and regenerative medicine research in the state of Maryland by working with scientists and various stakeholders to promote commercialization of stem cell technologies for treating patients at the bedside.
The Center for Breakthrough Medicines (CBM) announced today the appointment of Joseph (Joe) Lingle as Chief People Officer. In his role, Lingle will oversee all Human Resources (HR) activities, including talent management, workplace experience, and Diversity, Equity, and Inclusion (DE&I).